Skip to main content
. 2021 Jan 18;13(1):262. doi: 10.3390/nu13010262

Table 1.

Participant characteristics according to tertiles of the plasma concentration of trimethylamine-N-oxide (TMAO).

Characteristic All (n = 448) Tertile 1 (n = 147)
(<3.93 μmol/L)
Tertile 2 (n = 149)
(3.93 to 8.07 μmol/L)
Tertile 3 (n = 152)
(>8.07 μmol/L)
p-Value
Men, n (%) 238 (53.1%) 70 (47.6%) 79 (53.0%) 89 (58.6%) 0.17
Age, year 52.71 (13.09) 50.32 (13.14) 53.43 (12.64) 54.32 (13.23) 0.02
BMI, kg/m2 26.41 (4.79) 26.47 (5.01) 26.14 (4.37) 26.63 (4.97) 0.67
SBP, mmHg 135.85 (17.56) 135.25 (15.58) 134.47 (17.55) 137.77 (19.24) 0.24
DBP, mmHg 81.86 (10.95) 82.35 (10.49) 81.50 (10.85) 81.73 (11.54) 0.79
Heart Rate, bpm 67.97 (11.67) 68.20 (11.58) 68.03 (11.63) 67.69 (11.86) 0.93
Glucose, mmol/L 5.20 (4.70, 5.90) 5.30 (4.80, 5.70) 5.15 (4.70, 5.90) 5.30 (4.70, 6.00) 0.69
TG, mmol/L 1.88 (0.94) 1.80 (0.91) 1.89 (1.01) 1.95 (0.89) 0.21
TC, mmol/L 5.12 (1.14) 5.18 (1.15) 5.11 (1.19) 5.07 (1.08) 0.72
HDL-C, mmol/L 1.37 (0.46) 1.47 (0.48) 1.35 (0.44) 1.31 (0.46) 0.01
HbA1c, % 5.80 (5.50, 6.10) 5.80 (5.45, 6.25) 5.70 (5.40, 6.00) 5.80 (5.50, 6.10) 0.32
TMAO, μmol/L 5.66 (3.08, 11.20) 2.41 (1.44, 3.06) 5.62 (4.82, 6.69) 15.09 (11.08, 22.11) <0.001
eGFR, mL/min/1.73 m2 49.93 (19.38) 62.12 (16.70) 49.35 (15.58) 38.71 (18.23) <0.001
CKD stage, n (%) <0.001
G1 12 (2.7%) 8 (5.4%) 2 (1.3%) 2 (1.3%)
G2 125 (27.9%) 72 (49.0%) 38 (25.5%) 15 (9.9%)
G3a 115 (25.7%) 41 (27.9%) 47 (31.5%) 27 (17.8%)
G3b 128 (28.6%) 25 (17.0%) 47 (31.5%) 56 (36.8%)
G4 62 (13.8%) 1 (0.7%) 15 (10.1%) 46 (30.3%)
G5 6 (1.3%) 0 (0.0%) 0 (0.0%) 6 (3.9%)
UAE, mg/24 h 43.97 (11.75, 207.12) 37.70 (9.62, 177.82) 30.55 (8.48, 108.65) 90.03 (16.54, 384.67) <0.001
Current smokers, n (%) 56 (13.2%) 15 (11.1%) 16 (11.3%) 25 (17.0%) 0.24
Alcohol consumption, g/day 2.20 (0.04, 10.47) 2.01 (0.03, 11.33) 2.49 (0.06, 9.65) 2.62 (0.03, 10.33) 0.94
Total energy intake, kcal/day 2138.61 (613.46) 2204.56 (558.62) 2137.56 (650.91) 2072.21 (626.80) 0.21
Egg intake, g/day 8.93 (4.46, 14.29) 8.93 (4.46, 14.29) 7.14 (4.46, 14.29) 8.93 (7.14, 14.29) 0.25
Vegetable intake, g/day 107.00 (71.50, 147.90) 110.71 (81.69, 144.21) 112.67 (72.81, 156.02) 95.75 (65.83, 140.15) 0.10
Fruit intake, g/day 105.43 (49.71, 191.53) 90.11 (39.63, 178.02) 123.79 (53.07, 212.64) 99.43 (52.71, 191.41) 0.25
Fiber intake, g/day 20.86 (16.32, 26.39) 21.07 (15.88, 27.15) 21.47 (17.93, 28.23) 19.95 (15.28, 25.29) 0.08
Fish and sea food intake, g/day 10.81 (4.42, 18.71) 9.94 (3.89, 17.07) 10.69 (4.68, 16.93) 14.87 (4.68, 22.96) 0.02
Meat intake, g/day 83.82 (60.95, 100.30) 84.06 (59.58, 102.90) 80.51 (64.76, 98.25) 84.60 (59.92, 99.49) 0.86
Transplant vintage, year 4.95 (1.59, 11.54) 4.88 (1.79, 10.26) 4.08 (1.31, 10.58) 6.14 (1.76, 14.43) 0.09
Preemptive, n (%) 69 (17.5%) 28 (20.9%) 26 (20.3%) 15 (11.3%) 0.07
Living donor, n (%) 158 (35.3%) 62 (42.2%) 57 (38.3%) 39 (25.7%) 0.007
HLA-A,-B broad antigen mismatch, n (%) 0.99
0 94 (22.8%) 29 (21.6%) 32 (22.7%) 33 (23.9%)
1 97 (23.5%) 35 (26.1%) 33 (23.4%) 29 (21.0%)
2 151 (36.6%) 48 (35.8%) 51 (36.2%) 52 (37.7%)
3 46 (11.1%) 14 (10.4%) 16 (11.3%) 16 (11.6%)
4 25 (6.1%) 8 (6.0%) 9 (6.4%) 8 (5.8%)
HLA-DR broad antigen mismatch, n (%) 0.49
0 175 (42.6%) 60 (45.1%) 55 (39.0%) 60 (43.8%)
1 192 (46.7%) 60 (45.1%) 66 (46.8%) 66 (48.2%)
2 44 (10.7%) 13 (9.8%) 20 (14.2%) 11 (8.0%)
Tacrolimus, n (%) 68 (17.2%) 17 (12.7%) 22 (17.2%) 29 (21.8%) 0.14
Cyclosporine, n (%) 173 (43.8%) 48 (35.8%) 60 (46.9%) 65 (48.9%) 0.07
Azathioprine, n (%) 72 (18.2%) 21 (15.7%) 17 (13.3%) 34 (25.6%) 0.02
Mycophenolic acid, n (%) 262 (66.3%) 98 (73.1%) 90 (70.3%) 74 (55.6%) 0.005
Prednisolone dose, mg/day 10.00 (7.50, 10.00) 10.00 (7.50, 10.00) 10.00 (7.50, 10.00) 10.00 (7.50, 10.00) 0.42
Statins, n (%) 233 (52.0%) 70 (47.6%) 73 (49.0%) 90 (59.2%) 0.09
Diuretics, n (%) 177 (39.5%) 47 (32.0%) 55 (36.9%) 75 (49.3%) 0.007

Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BPM, beats per minute; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; UAE, urinary albumin excretion; HLA, human leukocyte antigen.